These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33203208)

  • 1. Fragment-Based Identification of Ligands for Bromodomain-Containing Factor 3 of
    Laurin CMC; Bluck JP; Chan AKN; Keller M; Boczek A; Scorah AR; See KFL; Jennings LE; Hewings DS; Woodhouse F; Reynolds JK; Schiedel M; Humphreys PG; Biggin PC; Conway SJ
    ACS Infect Dis; 2021 Aug; 7(8):2238-2249. PubMed ID: 33203208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of bromodomain factor 3 in Trypanosoma cruzi (TcBDF3) affects differentiation of the parasite and protects it against bromodomain inhibitors.
    Alonso VL; Ritagliati C; Cribb P; Cricco JA; Serra EC
    FEBS J; 2016 Jun; 283(11):2051-66. PubMed ID: 27007774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential Bromodomain
    Pezza A; Tavernelli LE; Alonso VL; Perdomo V; Gabarro R; Prinjha R; Rodríguez Araya E; Rioja I; Docampo R; Calderón F; Martin J; Serra E
    ACS Infect Dis; 2022 May; 8(5):1062-1074. PubMed ID: 35482332
    [No Abstract]   [Full Text] [Related]  

  • 4. Trypanosoma cruzi bromodomain factor 3 binds acetylated α-tubulin and concentrates in the flagellum during metacyclogenesis.
    Alonso VL; Villanova GV; Ritagliati C; Machado Motta MC; Cribb P; Serra EC
    Eukaryot Cell; 2014 Jun; 13(6):822-31. PubMed ID: 24747213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Bioactive Trypanosoma cruzi Bromodomain Inhibitor from Chemically Engineered Extracts.
    Ramallo IA; Alonso VL; Rua F; Serra E; Furlan RLE
    ACS Comb Sci; 2018 Apr; 20(4):220-228. PubMed ID: 29481050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine Learning Models and Pathway Genome Data Base for Trypanosoma cruzi Drug Discovery.
    Ekins S; de Siqueira-Neto JL; McCall LI; Sarker M; Yadav M; Ponder EL; Kallel EA; Kellar D; Chen S; Arkin M; Bunin BA; McKerrow JH; Talcott C
    PLoS Negl Trop Dis; 2015; 9(6):e0003878. PubMed ID: 26114876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The challenge of Chagas' disease: has the human pathogen, Trypanosoma cruzi, learned how to modulate signaling events to subvert host cells?
    Lima FM; Oliveira P; Mortara RA; Silveira JF; Bahia D
    N Biotechnol; 2010 Dec; 27(6):837-43. PubMed ID: 20172059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a Biologically Active Bromodomain Inhibitor by Target-Directed Dynamic Combinatorial Chemistry.
    García P; Alonso VL; Serra E; Escalante AM; Furlan RLE
    ACS Med Chem Lett; 2018 Oct; 9(10):1002-1006. PubMed ID: 30344907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multilocus polymerase chain reaction restriction fragment--length polymorphism genotyping of Trypanosoma cruzi (Chagas disease): taxonomic and clinical applications.
    Rozas M; De Doncker S; Adaui V; Coronado X; Barnabé C; Tibyarenc M; Solari A; Dujardin JC
    J Infect Dis; 2007 May; 195(9):1381-8. PubMed ID: 17397011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosomal bromodomain factor 1 from Trypanosoma cruzi enhances trypomastigote cell infection and intracellular amastigote growth.
    Ritagliati C; Villanova GV; Alonso VL; Zuma AA; Cribb P; Motta MC; Serra EC
    Biochem J; 2016 Jan; 473(1):73-85. PubMed ID: 26500280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Origins of Chagas disease: Didelphis species are natural hosts of Trypanosoma cruzi I and armadillos hosts of Trypanosoma cruzi II, including hybrids.
    Yeo M; Acosta N; Llewellyn M; Sánchez H; Adamson S; Miles GA; López E; González N; Patterson JS; Gaunt MW; de Arias AR; Miles MA
    Int J Parasitol; 2005 Feb; 35(2):225-33. PubMed ID: 15710443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity.
    Zingales B
    Acta Trop; 2018 Aug; 184():38-52. PubMed ID: 28941731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions Between Trypanosoma cruzi the Chagas Disease Parasite and Naturally Infected Wild Mepraia Vectors of Chile.
    Campos-Soto R; Ortiz S; Cordova I; Bruneau N; Botto-Mahan C; Solari A
    Vector Borne Zoonotic Dis; 2016 Mar; 16(3):165-71. PubMed ID: 26771702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of new potent hits against intracellular Trypanosoma cruzi by QSAR-based virtual screening.
    Melo-Filho CC; Braga RC; Muratov EN; Franco CH; Moraes CB; Freitas-Junior LH; Andrade CH
    Eur J Med Chem; 2019 Feb; 163():649-659. PubMed ID: 30562700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Trypanosoma cruzi RNA-binding protein RBP42 is expressed in the cytoplasm throughout the life cycle of the parasite.
    Tyler Weisbarth R; Das A; Castellano P; Fisher MA; Wu H; Bellofatto V
    Parasitol Res; 2018 Apr; 117(4):1095-1104. PubMed ID: 29473141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive glycoprofiling of the epimastigote and trypomastigote stages of Trypanosoma cruzi.
    Alves MJ; Kawahara R; Viner R; Colli W; Mattos EC; Thaysen-Andersen M; Larsen MR; Palmisano G
    J Proteomics; 2017 Jan; 151():182-192. PubMed ID: 27318177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the tool box for genetic manipulation of Trypanosoma cruzi.
    Burle-Caldas Gde A; Grazielle-Silva V; Laibida LA; DaRocha WD; Teixeira SM
    Mol Biochem Parasitol; 2015; 203(1-2):25-33. PubMed ID: 26523948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype diversity of Trypanosoma cruzi in small rodents and Triatoma sanguisuga from a rural area in New Orleans, Louisiana.
    Herrera CP; Licon MH; Nation CS; Jameson SB; Wesson DM
    Parasit Vectors; 2015 Feb; 8():123. PubMed ID: 25890064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Analysis of the Secretome and Interactome of
    Watanabe Costa R; Batista MF; Meneghelli I; Vidal RO; Nájera CA; Mendes AC; Andrade-Lima IA; da Silveira JF; Lopes LR; Ferreira LRP; Antoneli F; Bahia D
    Front Immunol; 2020; 11():1774. PubMed ID: 32973747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation between Trypanosoma cruzi and Trypanosoma rangeli using heat-shock protein 70 polymorphisms.
    Fraga J; Fernandez-Calienes A; Montalvo AM; Maes I; Dujardin JC; Van der Auwera G
    Trop Med Int Health; 2014 Feb; 19(2):195-206. PubMed ID: 24224809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.